S&P 500   3,896.66 (-0.13%)
DOW   31,577.05 (+0.13%)
QQQ   321.68 (-0.59%)
AAPL   126.50 (-1.01%)
MSFT   235.05 (-0.80%)
FB   265.39 (+0.18%)
GOOGL   2,079.25 (+0.46%)
TSLA   704.95 (-1.88%)
AMZN   3,143.58 (-0.08%)
NVDA   546.15 (-1.36%)
BABA   238.24 (-1.43%)
CGC   35.84 (+3.20%)
GE   13.06 (-0.38%)
MU   92.41 (-2.48%)
NIO   44.02 (-11.54%)
AMD   85.71 (-0.79%)
T   28.35 (+0.93%)
F   12.55 (+4.76%)
ACB   11.48 (+3.99%)
DIS   194.79 (-0.10%)
BA   224.42 (+0.01%)
NFLX   552.50 (+0.34%)
BAC   35.62 (-0.47%)
S&P 500   3,896.66 (-0.13%)
DOW   31,577.05 (+0.13%)
QQQ   321.68 (-0.59%)
AAPL   126.50 (-1.01%)
MSFT   235.05 (-0.80%)
FB   265.39 (+0.18%)
GOOGL   2,079.25 (+0.46%)
TSLA   704.95 (-1.88%)
AMZN   3,143.58 (-0.08%)
NVDA   546.15 (-1.36%)
BABA   238.24 (-1.43%)
CGC   35.84 (+3.20%)
GE   13.06 (-0.38%)
MU   92.41 (-2.48%)
NIO   44.02 (-11.54%)
AMD   85.71 (-0.79%)
T   28.35 (+0.93%)
F   12.55 (+4.76%)
ACB   11.48 (+3.99%)
DIS   194.79 (-0.10%)
BA   224.42 (+0.01%)
NFLX   552.50 (+0.34%)
BAC   35.62 (-0.47%)
S&P 500   3,896.66 (-0.13%)
DOW   31,577.05 (+0.13%)
QQQ   321.68 (-0.59%)
AAPL   126.50 (-1.01%)
MSFT   235.05 (-0.80%)
FB   265.39 (+0.18%)
GOOGL   2,079.25 (+0.46%)
TSLA   704.95 (-1.88%)
AMZN   3,143.58 (-0.08%)
NVDA   546.15 (-1.36%)
BABA   238.24 (-1.43%)
CGC   35.84 (+3.20%)
GE   13.06 (-0.38%)
MU   92.41 (-2.48%)
NIO   44.02 (-11.54%)
AMD   85.71 (-0.79%)
T   28.35 (+0.93%)
F   12.55 (+4.76%)
ACB   11.48 (+3.99%)
DIS   194.79 (-0.10%)
BA   224.42 (+0.01%)
NFLX   552.50 (+0.34%)
BAC   35.62 (-0.47%)
S&P 500   3,896.66 (-0.13%)
DOW   31,577.05 (+0.13%)
QQQ   321.68 (-0.59%)
AAPL   126.50 (-1.01%)
MSFT   235.05 (-0.80%)
FB   265.39 (+0.18%)
GOOGL   2,079.25 (+0.46%)
TSLA   704.95 (-1.88%)
AMZN   3,143.58 (-0.08%)
NVDA   546.15 (-1.36%)
BABA   238.24 (-1.43%)
CGC   35.84 (+3.20%)
GE   13.06 (-0.38%)
MU   92.41 (-2.48%)
NIO   44.02 (-11.54%)
AMD   85.71 (-0.79%)
T   28.35 (+0.93%)
F   12.55 (+4.76%)
ACB   11.48 (+3.99%)
DIS   194.79 (-0.10%)
BA   224.42 (+0.01%)
NFLX   552.50 (+0.34%)
BAC   35.62 (-0.47%)
Log in
NASDAQ:ESPR

Esperion Therapeutics Short Interest Ratio and Short Volume

$28.05
-0.47 (-1.65 %)
(As of 03/2/2021 12:50 PM ET)
Add
Compare
Today's Range
$28.05
Now: $28.05
$28.88
50-Day Range
$25.12
MA: $29.71
$36.89
52-Week Range
$23.90
Now: $28.05
$56.85
Volume73,599 shs
Average Volume971,996 shs
Market Capitalization$783.80 million
P/E RatioN/A
Dividend YieldN/A
Beta1.48

Short Interest

Esperion Therapeutics (NASDAQ:ESPR) Short Interest Data

Current Short Volume9,550,000 shares
Previous Short Volume10,140,000 shares
Change Vs. Previous Month:-5.82%
Dollar Volume Sold Short$261.57 million
Short Interest Ratio / Days to Cover11.7
Last Record DateFebruary, 12 2021
Outstanding Shares26,920,000 shares
Float Size26,880,000 shares
Short Percent of Float35.53%
Today's Trading Volume73,599 shares
Average Trading Volume971,996 shares
Today's Volume Vs. Average-92.43%

Short Interest Over Time


Esperion Therapeutics (NASDAQ:ESPR) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/12/20219,550,000 shares $261.57 million -5.8%35.5%11.7 $27.39
1/29/202110,140,000 shares $326.20 million -8.5%37.7%12.3 $32.17
1/15/202111,080,000 shares $355.89 million +2.8%N/A12.9 $32.12
12/31/202010,120,000 shares $317.36 million +3.5%44.0%15.5 $31.36
12/15/202010,120,000 shares $290.95 million +3.5%44.0%15.5 $28.75
11/30/20209,780,000 shares $275.80 million +0.9%42.5%16 $28.20
11/15/20209,690,000 shares $274.42 million -3.7%42.1%15.2 $28.32
10/30/202010,060,000 shares $288.62 million -0.7%43.7%16.3 $28.69
10/15/202010,130,000 shares $317.78 million -9.1%N/A17.5 $31.37
9/30/202011,140,000 shares $357.82 million -0.3%N/A18.6 $32.12
9/15/202011,170,000 shares $419.10 million -3.5%N/A18 $37.52
8/31/202011,570,000 shares $449.15 million +5.1%N/A17.6 $38.82
8/14/202011,010,000 shares $393.61 million +1.2%40.9%16.2 $35.75
7/31/202010,880,000 shares $368.83 million +3.8%40.7%15.8 $33.90
7/15/202010,480,000 shares $394.36 million +3.5%39.2%16.3 $37.63
6/30/202010,130,000 shares $404.90 million +8.1%37.9%15.4 $39.97
6/15/20209,370,000 shares $479.93 million +15.4%35.1%13.6 $51.22
5/29/20208,120,000 shares $369.78 million -2.8%30.4%10.4 $45.54
5/15/20208,350,000 shares $353.79 million +7.6%31.2%9.9 $42.37
4/30/20207,760,000 shares $308.46 million +2.0%29.0%8.2 $39.75
4/15/20207,610,000 shares $367.41 million +8.6%28.5%8.2 $48.28
3/31/20207,010,000 shares $281.31 million +12.9%26.9%7.8 $40.13
3/13/20206,209,100 shares $220.80 million -9.4%23.8%7.2 $35.56
2/28/20206,850,000 shares $244.89 million +30.2%26.3%9.6 $35.75
2/14/20205,260,000 shares $246.06 million +7.6%20.3%7.9 $46.78

Esperion Therapeutics (NASDAQ:ESPR) Short Interest FAQ

speech bubbles
speech bubbles











What is Esperion Therapeutics' current short interest?

Short interest is the volume of Esperion Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 12th, traders have sold 9,550,000 shares of ESPR short. 35.53% of Esperion Therapeutics' shares are currently sold short. View details.

What is a good short interest ratio for Esperion Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Esperion Therapeutics currently has a short interest ratio of 12.0.

What is a good short interest percentage for Esperion Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 35.53% of Esperion Therapeutics' floating shares are currently sold short.

Is Esperion Therapeutics' short interest increasing or decreasing?

Esperion Therapeutics saw a decline in short interest during the month of February. As of February 12th, there was short interest totaling 9,550,000 shares, a decline of 5.8% from the previous total of 10,140,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Esperion Therapeutics' float size?

Esperion Therapeutics currently has issued a total of 27,943,000 shares. Some of Esperion Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Esperion Therapeutics currently has a public float of 26,880,000 shares.

How does Esperion Therapeutics' short interest compare to its competitors?

35.53% of Esperion Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Esperion Therapeutics: Pacira BioSciences, Inc. (0.00%), OPKO Health, Inc. (24.08%), Rocket Pharmaceuticals, Inc. (0.00%), Amicus Therapeutics, Inc. (0.00%), Alkermes plc (0.00%), Corcept Therapeutics Incorporated (10.33%), Prelude Therapeutics Incorporated (3.36%), Viela Bio, Inc. (7.97%), IGM Biosciences, Inc. (13.59%), and Intra-Cellular Therapies, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Esperion Therapeutics stock?

Short selling ESPR is an investing strategy that aims to generate trading profit from Esperion Therapeutics as its price is falling. Esperion Therapeutics' stock is trading down $0.47 today. To short Esperion Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Esperion Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Esperion Therapeutics?

A short squeeze for Esperion Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ESPR, which in turn drives the price of the stock up even further.

How often is Esperion Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ESPR, twice per month. The most recent reporting period available is February, 12 2021.



This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.